Clearance Summary
INHANCETM Hybrid Anatomic Glenoid Implant received FDA 510(k) clearance under submission number K212933, sponsored by Depuy Ireland UC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2022-06-08.
- Submission: K212933
- Applicant / Sponsor: Depuy Ireland UC
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3670
- Decision date: 2022-06-08
Classification & Regulation
This clearance is catalogued under FDA product code MBF and 21 CFR 888.3670, within the Orthopedic review panel as a Class II device.